These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 14599482)
21. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression. Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962 [TBL] [Abstract][Full Text] [Related]
22. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. Bales KR; Tzavara ET; Wu S; Wade MR; Bymaster FP; Paul SM; Nomikos GG J Clin Invest; 2006 Mar; 116(3):825-32. PubMed ID: 16498501 [TBL] [Abstract][Full Text] [Related]
23. Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques. Apelt J; Ach K; Schliebs R Neurosci Lett; 2003 Mar; 339(3):183-6. PubMed ID: 12633883 [TBL] [Abstract][Full Text] [Related]
24. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. Praticò D; Uryu K; Leight S; Trojanoswki JQ; Lee VM J Neurosci; 2001 Jun; 21(12):4183-7. PubMed ID: 11404403 [TBL] [Abstract][Full Text] [Related]
25. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Schliebs R; Rossner S; Bigl V Prog Brain Res; 1996; 109():253-64. PubMed ID: 9009714 [TBL] [Abstract][Full Text] [Related]
26. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Bi Oh S; Suh N; Kim I; Lee JY Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795 [TBL] [Abstract][Full Text] [Related]
27. Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Kouznetsova E; Klingner M; Sorger D; Sabri O; Grossmann U; Steinbach J; Scheunemann M; Schliebs R Int J Dev Neurosci; 2006; 24(2-3):187-93. PubMed ID: 16423498 [TBL] [Abstract][Full Text] [Related]
28. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567 [TBL] [Abstract][Full Text] [Related]
29. Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice. Machová E; Rudajev V; Smycková H; Koivisto H; Tanila H; Dolezal V Neurobiol Dis; 2010 Apr; 38(1):27-35. PubMed ID: 20053373 [TBL] [Abstract][Full Text] [Related]
30. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686 [TBL] [Abstract][Full Text] [Related]
31. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques. Kalback W; Watson MD; Kokjohn TA; Kuo YM; Weiss N; Luehrs DC; Lopez J; Brune D; Sisodia SS; Staufenbiel M; Emmerling M; Roher AE Biochemistry; 2002 Jan; 41(3):922-8. PubMed ID: 11790115 [TBL] [Abstract][Full Text] [Related]
32. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease. Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978 [TBL] [Abstract][Full Text] [Related]
33. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432 [TBL] [Abstract][Full Text] [Related]
34. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835 [TBL] [Abstract][Full Text] [Related]